Establishing ranges of clinical normal limits and comparison with adopted limits for adult population by Yared Mekonnen et al.
 
Original article  
  
Establishing ranges of clinical normal limits and 
comparison with adopted limits for adult 
population  
  
Yared Mekonnen1, Gebeyehu Damecha1 and Cherinet Ambaye 1  
  
Abstract: It is important to know the normal limits for each test in each laboratory.  In most cases 
the normal limits established by others have been adopted and used as reference values.  In view of 
this an attempt is made in this paper to establish ranges of clinical normal limits for adults.  Eight 
determinations SGOT, SGPT, ALP, BILD, BILT, FBS, UREA, and CREATININE were included 
in the study.  Normal limits were established based on a validated statistical method.  Comparision 
was made with adopted normal limits in use in laboratories.  For most tests notable differences in 
limits, particularly from the side of abnormal values, have been observed which resulted in high 
misclassification of laboratory test values. [Ethiop. J. Health Dev. 1997;11(2):97-101]  
  
Introduction  
   Factors including sex, age, exercies, diet, emotion, posture, tourniquet, drugs, and fluid intake are 
examples of things known to affect certain tests (1).  Surveys have shown that the normal ranges 
which laboratories report have little relation to results of their tests of survey specimens since they 
adopted ranges established for different populations.  It is important for a laboratory to know what 
normal limits of each procedure are in its hand.  In most instances the normal limits established for 
different populations have been adopted, even though problem of standardization and idiosyncrasies 
of individual laboratory may make these quite erroneous (2).  
   The concept of ‘normal ranges’ evolved as statistical methods were applied to laboratory medicine 
since 1951.  In 1951, Wooton applied statistical methods for calculating normal range estimates of 
healthy volunteers (3). Following this several writers have devised different methods of estimating 
normal ranges.  Basically there are two approaches in establishing normal limits.  One can establish 
normal limits from healthy individuals which is  considered  as  a gold  standard procedure.   
Data can be collected from healthy individuals and normal ranges could be established.  However, 
the procurement and analysis of specimens from a large number of representative normal subjects 
is expensive and difficult.  Experience has shown that for most clinical laboratories and most type 
of tests the great bulk of the routine samples for which analysis is requested are usually within 
normal limits.  In addition, the great majority of abnormal values tend to be on a single side of the 
normals for most tests (4).  It has been suggested that the accumulation of values for healthy persons 
is unnecessary and the clinical limits can be established from routine data by a purely statistical 
method which is regarded as a second approach for establishing normal limits.  
                                                          
1 From the Ethiopian Health and Nutrition Research Institute P.O. Box 1242, Addis Ababa, Ethiopia 
presented a method for estimating mean and standard deviation of a Gaussian distribution in the 
presence of one sided ‘contamination’, the side of contamination being known.  He extensively 
explored the properties of estimates made by such methods under various known conditions of 
contamination by means of computer simulation and he has proved the estimation procedure to be 
robust for practical application.  He, pointed out, however, that his contribution was in establishing 
and validating a statistical method, not in testing whether the underlying assumptions, were valid in 
actual application.  In view of this a study involving 18 determinations to validate his procedure has 
been done.  The study concluded that in using his method no evidence for systematic bias in 
characteristic value, dispersion, or position of limit on side of contamination has been seen when  
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   Becktel developed a method for establishing normal limits from routine laboratory data.  He 
______________________________________  
compared with those limits derived from healthy individuals (2).  Therefore, his method has been 
proved and recommended as a valid and useful method for setting normal limits in the laboratory.    
The normal limits used by the laboratories in this country are specified by proprietors elsewhere in 
the world. The applicability of these limits for Ethiopian population is questionable since several 
factors influence normal limits. Thus, It is worth trying to establish normal limits for the Ethiopian 
population and compare it with adopted ones, to determine the need to establish local normal limits.  
  
Methods  
   Data was obtained from records of the Clinical Chemistry Laboratory of the Ethiopian Health and 
Nutrition Research Institute. For each clinical test under study a random sample was selected from 
the routine data of the year 1995.  In the analysis only those aged over 20 were included.  All tests 
under study were performed on Coulter KEM-O-MAT2, Phase 2 HP85, by kinetic assay 
measurement as part of the routine diagnostic service. The normal reference limits in use in 
laboratories are adopted from Coulter reagent kit, except for the enzymes, SGOT and SGPT,  the 
reference values of which were obtained from Boehringer Manheim reagent kit.  
   The method employed to estimate the normal limits based on the routine data is a validated 
statistical procedure for estimating the mean and standard deviation of a Gaussian distribution in the 
presence of one sided 'contamination' which is developed by Becktel - Becktel's Method.  Carefully 
selected samples of about 40 to 50 specimens yield an acceptable estimate from presumed normals 
(5).  The Bektel procedure, however, requires about 2.5 times as many hospital subjects to achieve 
the same precision of estimates as can be obtained with a given number of presumed normals (2).  
Thus, a sample size of at least 125 will be required to apply the method. In general large sample 
sizes would be more preferable. All the tests under consideration satisfy the required sample size.  
For each test, sample size was computed according to the weight (frequency of occurrence) of each 
test.  The most frequently occurring test, ALP, has for example the largest sample size compared to 
others.  On the other hand, the least frequently occurring test, BILT, has the smallest sample size 
(Table 2).  It is assumed that the bulk of the observations are from a Gaussian distribution and it is 
also assumed that the bulk of abnormal values are not too near the mean of those values from 
'healthy' individuals for that test.  In particular the latter assumption demands estimation of the mean 
either by the point of greatest concentration of observed values (the mode) or by the median of the 
observed values, depending on which is farther from the end known to contain the abnormal values, 
if any.  In the estimation of the mode, the first step involved is to rank the observations in order of 
magnitude (X1 to XN).  From the total number of observation, N, we find J, the largest odd number 
not greater than N/2.  Then we calculate the difference XJ - X1, X(J+1) - X  2,..., X  N - X   (N-J+1). If there 
is a unique smallest difference, then the mode is the observation corresponding to the average of the 
ranks giving the smallest difference.  If the average of the ranks giving the smallest difference is 
greater than (N+1)/2 (if N is odd) or ((N/2) +((N/2)+1))/2 (if N is even), then the mean is estimated 
by the median.  
   When the Mode can be used as estimate of the mean of normal values encompassed, the number 
of such 'uncontaminated' observations, Nl, is estimated based on the presence of equal numbers (of 
‘normal’ values) below and above the mean.  If, however, the data are such that the mean is estimated 
by the median of the sample values, then Nl = N.  Based on the estimated number of 
‘uncontaminated’ or 'normal' values, Nl, percentiles will be calculated.  For tests with high abnormal 
values, the 5th, 10 th, 15 th, 20 th, 25 th and 30   th percentiles will be used and for those tests with low 
abnormal values the percentiles used are the 70 th, 75 th, 80 th, 85 th, 90 th and the 95   th.  Linear 
interpolation will be employed when the desired percentile lies between two different values. The 
standard deviation is then estimated by the difference between the estimated mean and the average 
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of the six specified percentiles. Finally estimates of a 95% normal range for each of the tests were 
computed.  
   For many laboratory tests the distribution of values in normal subjects tends to be more nearly 
loggaussian than arithmetic gaussian (4).  For those tests with coefficient of variation (sd/mean) 
more than 20% logarithmic transformation is required and the final limits are transformed back to 
the original scale.  The coefficient of variations of all the test were found to be more than 20% and 
logarithmic transformations were performed for all of the tests under study (Table 2).  Data entry 
and analysis was performed using EPI-INFO and LOTUS-123 computer programmes.  
  
Result  
   Laboratory test results of the eight determination under study have been presented according to 
the adopted standard (Table 1).  For all of the tests, except for FBS, the highest proportion (more 
than 70%) of the test results are in the normal range and in most of these tests the proportion of 
abnormal results found to be less than 20 %.  In addition few results fall below the lower limit of the 
range.  Therefore, one can easily understand that most of the results are within the normal limits of 
the adopted standard.  Though most of the patients for whom analysis requested are those who are 
unhealthy and there are few Ethiopians who seek medical check up, the great majority of the routine 
samples are within  the  normal  ranges  of  the  adopted  
  
Table 1:  Laboratory Results by the adopted standard  
  Normal range                              Result    
Tests  sex    Normal    Abnormal  below  
SGOT       M        9-30  212(73.4%)      73(25.3%)       4(1.4%)  
               F         7-26  219(77.7%)       62(22.0%)      1(0.4%)  
SGOT        M        8-42   229(79.8%)      54(18.8%)       4(1.4%)  
               F         6-27  227(80.5%)      55(19.5%)       NONE  
ALP       M + F    80-220   441(80.2%)     108(19.6%)      1(0.2%)  
BILD        M + F    0.2-0.8   383(90.3%)      34(8.0%)        7(1.7%)  
BILT        M + F    0.5-1.5   349(85.3%)      37(9.0%)     2  23(5.6%)  
FBS         M + F    60-110   254(49.4%)      253(49.2%)      7(1.4%)  
UREA       M + F    13-45   471(87.2%)      59(10.9%)   1   10(1.9%)  
                 M       0.7-1.6   200(85.8%)      25(10.7%)      8(3.4%)  
CREAT       F        0.4-1.2   233(81.5%)        52(18.5%)       NONE  
  
standards.  In addition, most of the abnormal results are concentrated on the upper side of the limit 
(Table 1). Therefore, the data at hand satisfies all the necessary conditions to apply the Becktel's 
method. The presence of abnormal results is always expected, however, the most important thing is 
that the majority of these abnormal values should concentrate on the upper side of the limit.   
  
  
Table 2:  Sample size, Mean, Standard deviation and coefficient of variation of each of the tests  
               Sex          N  Mean*              SD          CV**   
 SGOT        M        289    36.41     68.34     187.69   
                F           282      26.06    32.99     126.59   
SGOT       M        287     36.11    73.84       204.48   
               F           282    23.60    37.02       156.86   
ALp        M & F    550     194.78   157.87      81.05   
BILD         M & F    424     0.57      1.28        224.56    
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BILT          M & F    409     1.11      1.81        163.06   
FBS           M & F    514     154.05   98.06      63.65   
UREA        M & F    540     32.05     27.28     85.11   
CREATE   M          233     1.47      1.51        102.72   
   F           286     1.21      1.28        105.78   
* Arithmetic mean** CV (Coefficient of Variation) 
= (SD/MEAN) *100     
   Arithmetic Mean, Standard deviation (SD) and Coefficient of Variation (CV) of estimates is 
presented in Table 2.  All the tests under study have CV larger than 20 % and the distribution of 
values tends to be more nearly log-Gaussian than arithmetic Gaussian.  Thus   
  
Table 3:  Estimated Mean and standard deviation of the logarithmic transformed data and number of uncontaminated 
observations (Nl) based on the method.  
  Sex    Nl  Estimated Mean  Estimated1 SD  
SGOT       M          202      1.063257*      0.140863   
                 F           206      1.02328*       0.152811   
SGOT       M          212      1.20412*       0.188812   
                 F           170      0.91046*       0.149811   
Alp           M & F   409      2.12385*       0.108705   
BILD        M & F   424     -0.45593**      0.17609   
BILT           M & F    250     -0.22185*       0.09533   
FBS          M & F   313      1.98227*       0.07871   
UREA       M & F    535      1.41497*       0.18180   
CREAT.     M         202      0.04139*       0.09099   
    F           286      0.00000*       0.09919   
* mean estimated by mode (N > Nl)  
** mean estimated by median (N = Nl)  
1 SD= estimated mean - average of the six percentiles  
  
logarithmic transformation was performed on the original data.  According to the method means and 
standard deviations of the transformed data were computed for each test.  Except for BILD, where 
the mean estimated by the median, it is the mode which served as an estimate of the mean. In the 
case where the mode is used to estimate the mean the number of uncontaminated values, Nl, were 
computed and found to be less than the sample size (Table 3).  The percentiles used in the method 
are the 5th, 10th, 15th, 20th, 25th, and 30th, since all of the tests under consideration have high 
abnormal values.    
   Only for three of the tests normal limits were presented by sex.  The estimated limit for SGOT 
were found to be almost similar for both sexes, though, minor difference has been observed 
particularly from the lower side of the limit. Limits of SGPT have shown notable differences by sex, 
in particular, from the upper side of the limit (38.2 Vs 23).  Such difference, though not very high 
has also been counted for Creatinine from both sides of the limit (Table 4).  Adopted limits which 
are currently in use in laboratories in our country have been presented for comparison purpose. In 





Table 4:  Estimated and Adopted Ranges of normal values by sex, and percent misclassified  





            Sex        Side of        
Abnormal Value     
Estimated 
Normal  
*  Limit         
      Adopted      




SGOT       M   high        8.4 -30.6   9 -30   NONE  
      F   high        7.4 -30.3  7 -26  4.6 %  
SGOT       M   high        6.7 -38.2  8 -42  3.8 %  
               F   high        5.8 -23  6 -27  7.1 %  
ALP       M & F  high        80.6 -220  80 -220  NONE  
BILD      M & F  high        0.13 -0.67  0.2 -0.8  1.9 %  
BILT       M & F  high        0.39 -0.93   0.5 -1.5   11.0 %  
FBS        M & F  high        67 -139  60 -110  13.0 %  
UREA      M & F  high        11.3 -60  13 -45  5.7 %  
CREAT.     M        high       0.72 -1.67  0.7 -1.6  NONE  
                  high       0.64 -1.58  0.4 -1.2  10.5 %  
  
* Normal limits in original scale  
** Normal limits currently in use in laboratories  
SGOT= Serum Glutamate Oxaloacetate Transaminase - unit (iu/l)  
SGPT = Serum Glutamate Pyruvate Transaminase - unit (iu/l)  
ALP= Alkaline Phosphatase - unit (iu/l)  
BILD= Bilirubin Direct - unit (mg/dl)  
BILT= Bilirubin Total - unit (mg/dl)  
FBS= Fasting Blood Sugar - unit (mg/dl)  
UREA= Urea - unit (mg/dl)  
CREAT= Creatinine - unit (mg/dl)   
  
have been observed and no laboratory test value was misclassified (Table 4). In the rest of the tests 
discrepancies have been noticed.  When compared to the estimated normal limits 13 % (67/514) of 
laboratory test values have been misclassified in FBS and were false positive, particularly from the 
upper side of the limit (138 Vs 110).  In the case of BILT, the misclassification is also high where 
11 % (45/409) of the test values were false negatives which occurred from the upper side of the limit 
(0.93 Vs 1.5).  For Creatinine 10.5 % (30/286) of the laboratory test values have been misclassified 
for females and were false positive.  Such misclassification can also be seen in limits of SGPT for 
female (7.1 %), UREA (5.7 %), SGOT for female (4.6 %), SGPT for male (3.8 %) and BILD (1.9 
%) particularly from the upper side of the limit (Table 4).  Except for three of the tests, the estimated 
and adopted normal limits under study have shown dissimilarities particularly from the upper side 
of the limit where the misclassification occurred.  In general the adopted limits were found to 
misclassify laboratory test values either as false positive or false negative.    
 




   Though normal limits could be established from a large group of presumed normals experiences have shown that it 
is an expensive and difficult task.  Taking this fact into account, a validated statistical method has been used to establish 
normal limits from routine laboratory records.  The method has been proved to be a workable, relatively unbiased, and 
simple for estimating normal limits from routine clinical experience of a laboratory and recommended for clinical use 
(2).  Therefore, any laboratory could establish its own normal limits at no extra cost other than the computation time 
involved.  Moreover, repeated determinations of normal limits over a period of time can serve as a form of quality 
control in laboratories.  
   In general, the adopted normal limits for most of the tests do not represent the population under study.  The 95% 
confidence limit nearely overlap one another only in three of the tests.  However, most of the limits under examination 
show major discrepancies.  For most of the tests the adopted limits are found to misclasify laboratory test values either 
as false positive or as false negative.  This clearely shows the urgency and need of establishing normal limits for 
Ethiopians. In this study normal limits were established only for eight of the tests performed in clinical laboratories, 
although there are other such tests which need to be studied.  One can consider this as an attempt towards establishing 
normal limits for Ethiopian populations at large.  The aim of this study is not to give explanation for the dissimilarities 
obeserved between the adopted and the established normal limits.  It is rather to bring to one's attention the fact that, 
given the urgency for each laboratory to establish its own normal limits, there exists a simpler, clinically validated and 
statistically sound method for estimating normal limits from routine laboratory data.  The need for such a less 
expensive and less difficult method would be more evident when one considers the fact that normal limits should not 
only be established but should also be verified and updated from time to time.  Regarding the biochemical and other 
possible scientific explanations for the observer differences between the established and adopted limits, this study has 
nothing to contribute.  It is important, however to note that normal limits can affect patient's treatment and therefore, 
problems associated with misclassification of laboratory test values would be real and important.  
   Data for this study is taken from records of one laboratory, therefore, the established normal limits might not represnt 
the population of Ethiopia.  Thus, it is recommended to carry out such studies in the diferent regions of the country in 
order to have good representation of the population. The inclusion of other laboratory tests which are not examined in 
this paper would be essentail.  
  
Acknowledgement  
   The authors would like to thank the Ethiopian Health and Nutrition Research Institute for all the support given to 
carry out the research.   
  
Reference  
1. Robert G. Hoffmann. Establishing Quality Control and Normal Ranges in the Clinical Laboratory.  New 
York. 1971.  
2. Best W R, Mason CC, Barron SS, et al. Validation of Procedure for Setting Normal Limits on the Basis of 
Total Laboratory Experience. Clin Chim Acta 1970;28:127-132.  
3. Wooton IDP, King EJ, Smith MB. The Quantitative Approach to Hospital Biochemistry. Brit Med Bull 
1951;7:307. 4.  Becktel JM. Simplified Estimation of Normal Ranges From Routine Laboratory Data. Clin Chim Acta 
1970;28:119-125.  
5.  Mary F, Massod BS. Nonparametric Percentile Estimate of Clinical Normal Ranges. American Journal of Medical 
Technology 1976;43:243-252.  
  
